Cryoport
Cryoport (NASDAQ: CYRX) provides temperature-controlled supply chain and cryogenic storage solutions for the Life Sciences industry, serving biopharmaceutical, animal husbandry, and reproductive medicine companies across 15+ global locations with 700+ employees.
- Company typePublic
- Founded1990
- HeadquartersBrentwood, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Cryoport does
Cryoport, Inc. (NASDAQ: CYRX) is a global provider of temperature-controlled supply chain solutions for the Life Sciences industry, headquartered in Brentwood, Tennessee with manufacturing in Brea, California and operations across 15+ locations in the Americas, EMEA, and APAC. The company operates three business units — Cryoport Systems (integrated temperature-controlled logistics), MVE Biological Solutions (cryogenic storage and shipper systems, with over 50 years of brand heritage), and CRYOGENE (U.S.-based medical biorepository for biological specimen storage). Its product portfolio centers on reusable cryogenic dry vapor shippers (AR1000, DG1000, DS650) capable of maintaining temperatures below -150°C for up to 10-16 days, plus the Advanced Therapy Shippers (ATS) line purpose-built for cell and gene therapies and the Cryoport Elite Ultra Cold Shipper for dry-ice-based transport. The company holds IATA dangerous goods certifications, multiple patents on cryogenic container technology, and operates the Cryoportal.com logistics management platform.
The business model combines three revenue streams: hardware sales of reusable cryogenic shippers ($685-$1,095 per unit), recurring cycle-fee leasing of shipper units on 15-day Standard Cycles under multi-year contracts, and managed biostorage and sample processing services through CRYOGENE. Go-to-market is sales-led, combining a direct enterprise sales team with third-party distributors and agents (Liquide, SCA Thermosafe, exclusive South American agent CryoPort Systems Ltda.). The customer base spans biopharmaceutical and life sciences companies (primary), animal husbandry, reproductive medicine/IVF, universities and research institutions, and government agencies. The company was originally incorporated in Nevada in 1990 as G.T.5-Limited, acquired CryoPort Systems, Inc. via a share exchange in March 2005, and adopted the CryoPort name and current business focus. Leadership is anchored by Chairman, President, and CEO Jerrell W. Shelton (appointed November 2012), with a board that includes representation from Blackstone's healthcare team.
Cryoport firmographics
Firmographics- Name
- Cryoport
- Legal name
- Cryoport Systems, LLC
- Website
- https://cryoportinc.com
- Company type
- Public
- Founded year
- 1990
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Cryoport (NASDAQ: CYRX) provides temperature-controlled supply chain and cryogenic storage solutions for the Life Sciences industry, serving biopharmaceutical, animal husbandry, and reproductive medicine companies across 15+ global locations with 700+ employees.
- Ownership category
- akta.pro rank
Cryoport industry classification
Industry- Product category
- Cryogenic Life Sciences Logistics and Storage
- NAICS
- Air-Conditioning and Warm Air Heating Equipment and Commercial and Industrial Refrigeration Equipment Manufacturing (333415), Refrigerated Warehousing and Storage (493120)
- SIC
- Air-Cond & Warm Air Heatg Equip & Comm & Indl Refrig Equip (3585)
- akta.pro primary industry
- Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low) (HLAGAGAK)
- akta.pro secondary industries
- Cryogenic Logistics (LN2 Dry Shippers, -150°C) (HLAGAMAB), Cryogenic / Ultra-Low Temperature Transport (e.g., dry ice, LN2) (TLADAHAJ), Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats) (HLAGAIAJ), Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies (HLAAAJAN), Cryogenic & Ultra-Low Temperature Logistics (-80°C, LN2 Dry Shipper) (TLAIAIAK)
Keywords
Where Cryoport is headquartered
LocationHeadquarters
- HQ city
- Brentwood
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Cryoport business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Cryogenic Shipping Container Sales: Sale of reusable cryogenic dry vapor shippers (AR1000, DG1000, DS650) and related products
- Shipper Unit Leasing Services: Cycle Fee-based leasing of shipper units with Standard Cycles of 15 days. Customers pay lease rate fees per Standard Cycle with additional fees for extended use or non-return of units.
- Biostorage and Sample Processing: Services provided through CRYOGENE biorepository for secure storage of biological research specimens and associated supplies
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Standard Cycle Fee - 15-day lease period |
| One time/ perpetual license | One time/ perpetual license | Cryogenic Storage Systems |
| One time/ perpetual license | One time/ perpetual license | Disposable/One-Way Shippers (Future) |
Go-to-market motion1 record
Distribution channels5 records
Marketing channels2 records
Cryoport product offering
Product offeringCore offering
Cryoport, Inc. designs, manufactures, and leases temperature-controlled cryogenic shipping containers and storage systems for the Life Sciences industry through its Cryoport Systems, MVE Biological Solutions, and CRYOGENE business units. It also provides biostorage, sample processing, and temperature-controlled logistics support for biopharmaceutical, animal husbandry, and reproductive medicine customers, with cryogenic shippers that maintain temperatures of -150°C or below for 10-16 days and are IATA-certified for dangerous goods transport.
Product overview
Cryoport offers a comprehensive portfolio of temperature-controlled supply chain solutions for the Life Sciences industry, organized across three primary business units: Cryoport Systems (temperature-controlled logistics), MVE Biological Solutions (cryogenic storage and shipper systems), and CRYOGENE (biorepository services). The product portfolio includes Advanced Therapy Shippers™ for cell and gene therapy transport, the Cryoport Elite™ Ultra Cold Shipper for dry ice-based shipping, and reusable cryogenic dry vapor shippers including the AR1000, DG1000, and DS650 models. Customers interact with the platform through Cryoportal.com for order processing and shipment management. The company operates across 15+ global locations serving biopharmaceutical, animal husbandry, and reproductive medicine companies.
Differentiator
Problem solved
Functional benefit
Brands
- Cryoport Systems: Market leader in globally integrated temperature-controlled supply chain support for the Life Sciences industry.
- MVE Biological Solutions
- CRYOGENE
Products and services
- Cryoport Systems Market leader in globally integrated temperature-controlled supply chain support for the Life Sciences industry, providing cryogenic shipping solutions for biopharmaceutical, animal husbandry, and reproductive medicine customers.
- MVE Biological Solutions Cryogenic storage and shipper systems for the Life Sciences industry, with over half a century of experience as the preferred choice for cryogenic solutions, offered under the MVE brand.
- CRYOGENE Leading U.S.-based medical biorepository focused on secure storage of biological research specimens and associated supplies, serving research institutions and life sciences customers.
- Advanced Therapy Shippers (ATS) Temperature-controlled shipping containers specifically designed for transporting cell and gene therapies containing human clinical and/or commercial product, compliant with IATA classifications for Biological Substance, Category B and related materials. For biopharmaceutical customers developing and commercializing advanced therapies.
- Cryoport Elite Ultra Cold Shipper Dry ice-based ultra cold shipping container for temperature-sensitive biological materials, with specific requirements for dry ice removal prior to return. For Life Sciences customers requiring ultra-cold transport applications.
- AR1000 Reusable cryogenic dry vapor shipper utilized primarily in veterinary and human assisted reproduction markets, capable of maintaining temperatures below -150°C for up to 10 days. Priced from $685 to $1,095 per unit.
- DG1000 Reusable cryogenic shipper designed for shipping biological materials classified as dangerous goods by IATA standards, IATA certified for shipment of Class 6.2 Dangerous Goods under Packing Instruction 602. Priced from $685 to $1,095 per unit.
- DS650 Reusable cryogenic shipper for shipment of specimens for diagnosis, treatment or evaluation of disease, conforming to IATA Packing Instruction 650 packaging standards. Priced from $685 to $1,095 per unit.
- Shipper Unit Leasing Services Cycle Fee-based leasing of Cryoport shipper units with Standard Cycles of 15 days. Customers pay lease rate fees per Standard Cycle, with additional Cycle Fees for units not returned within the Standard Cycle and extended cycles available in 5-day increments at an additional 33.33% fee. For Life Sciences customers running clinical and commercial cryogenic logistics.
- Biostorage and Sample Processing Biostorage and sample processing services provided through the CRYOGENE biorepository for the secure storage of biological research specimens and associated supplies. For research institutions, universities, and biopharmaceutical customers.
Quantifiable outcome
- Maintain cryogenic temperatures of -150°C or less for up to 10 days (functional hold time in shipping use) and up to 16 days (maximum guaranteed under static conditions)
Companies that use Cryoport
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles4 records
Cryoport technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Cryoport partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- CryoPort Systems Ltda.coreExclusive South American sales agent based in Sao Paulo, Brazil. Provides 17% commission for all sales in South American countries under a ten-year agreement expiring August 9, 2011.
- LiquideminorThird-party reseller relationship for Cryoport products
- SCA ThermosafeminorThird-party reseller relationship for Cryoport products
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Cryoport competitors and assessment
Company assessmentEmerging players
- Vineti: Vineti provides a cloud-based platform for cell & gene therapy supply chain management, including chain of custody and patient scheduling. While focused on software rather than physical cryogenic logistics, it addresses similar cold chain orchestration challenges that Cryoport's Cryoportal.com platform targets.
- Sartorius AG: Sartorius provides bioprocessing equipment and consumables for cell & gene therapy manufacturing, including some cryopreservation and cold chain-adjacent products. While primarily a bioprocessing-focused company, it offers storage and handling technologies that intersect with Cryoport's biopharma manufacturing services.
- BioLife Solutions: BioLife Solutions provides biopreservation tools, cryopreservation media, and cold chain shipping products for the cell & gene therapy industry. While focused more on consumables and storage media than full-service logistics, it competes with Cryoport's CRYOGENE biorepository and adjacent cryopreservation offerings.
Direct peers
- Azenta Life Sciences (formerly Brooks Life Sciences): Azenta provides biological sample storage, biorepository services, and cold chain logistics for the life sciences industry. Its sample management and biorepository offerings directly compete with Cryoport's CRYOGENE unit, and the company has expanded into temperature-controlled transport services.
- Marken (UPS Healthcare): Marken is a global specialty courier for the life sciences industry, offering temperature-controlled and cryogenic logistics for clinical trials and cell & gene therapies. As a subsidiary of UPS Healthcare, it directly competes with Cryoport Systems in the same biopharma cold chain logistics market with comparable service offerings.
- World Courier (Cencora): World Courier is a global specialty logistics provider serving the biopharmaceutical industry with temperature-controlled and cryogenic shipping capabilities. Owned by Cencora (formerly AmerisourceBergen), it competes directly with Cryoport Systems for clinical trial specimen transport and commercial therapy distribution.
- QuickSTAT (a Kuehne+Nagel company): QuickSTAT is a global specialty courier specializing in time-sensitive and temperature-controlled logistics for clinical trials, biological samples, and cell therapies. Now part of Kuehne+Nagel, it competes directly with Cryoport in life sciences cold chain logistics with similar target customers.
Broad incumbents
- Cytiva (Danaher): Cytiva is a global life sciences tools and bioprocessing provider owned by Danaher, offering products for cell therapy manufacturing including cryopreservation and cold storage solutions. As a broad incumbent, it competes with Cryoport's offerings to cell & gene therapy developers through its comprehensive bioprocessing portfolio.
- Thermo Fisher Scientific: Thermo Fisher Scientific is a diversified life sciences tools and services giant offering cryogenic storage equipment through its laboratory products division. While it does not specialize in cryogenic logistics like Cryoport, it competes in adjacent product categories including biological storage systems and biopreservation consumables.
Regional players
- Hyperion Logistics (formerly QuickSTAT competitor, Spanish pharma courier): Hyperion Logistics is a European specialty courier offering temperature-controlled and time-critical logistics for clinical trials and biopharmaceuticals. It competes with Cryoport in the EMEA region for life sciences cold chain services with comparable cryogenic handling capabilities.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Cryoport social profiles
Digital presenceCryoport financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cryoport leadership team
Management profileNumber of profiles
Profiles7 records
Cryoport subsidiaries and ownership
Company hierarchySubsidiaries3 records
Cryoport funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cryoport M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cryoport
What does Cryoport do?
Cryoport, Inc. designs, manufactures, and leases temperature-controlled cryogenic shipping containers and storage systems for the Life Sciences industry through its Cryoport Systems, MVE Biological Solutions, and CRYOGENE business units. It also provides biostorage, sample processing, and temperature-controlled logistics support for biopharmaceutical, animal husbandry, and reproductive medicine customers, with cryogenic shippers that maintain temperatures of -150°C or below for 10-16 days and are IATA-certified for dangerous goods transport.
Is Cryoport a public or private company?
Cryoport is a public company. It is classified as public and is currently operating.
When was Cryoport founded?
Cryoport was founded in 1990. It employs 1 to 10 people.
Where is Cryoport based?
Cryoport is headquartered in Brentwood, United States, in the North America region.
How does Cryoport make money?
Three revenue lines are on record. Cryogenic Shipping Container Sales are the primary driver. The others are shipper Unit Leasing Services and biostorage and Sample Processing.
Who are Cryoport's main competitors?
Emerging players on record are Vineti, Sartorius AG and BioLife Solutions. Direct peers are Azenta Life Sciences (formerly Brooks Life Sciences), Marken (UPS Healthcare), World Courier (Cencora) and QuickSTAT (a Kuehne+Nagel company). Broad incumbents are Cytiva (Danaher) and Thermo Fisher Scientific. Hyperion Logistics (formerly QuickSTAT competitor, Spanish pharma courier) is listed as a regional player.
Does Cryoport have an API?
No public API is recorded for Cryoport.
What industry is Cryoport in?
Cryoport's product category is Cryogenic Life Sciences Logistics and Storage. Its primary akta.pro industry code is HLAGAGAK, Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low), with a secondary code of HLAGAMAB, Cryogenic Logistics (LN2 Dry Shippers, -150°C). Its NAICS code is 333415 and its SIC code is 3585.